Company / Assets per Share
RAPT Therapeutics, Inc. Assets per Share History
FY2018-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$5.90
FY2024
5-year range
$4.52 / $8.18
FY2020-FY2024
Trend
+30.4%
vs FY2023
Sector context
#137 of 208
Health Care
What the data says
At $5.90, RAPT Therapeutics, Inc.'s assets per share ranks #137 of 208 in the Health Care sector. Assets per Share has fluctuated over the past 7 years, ranging from $4.52 in FY2023 to $111.86 in FY2018.
Based on SEC 10-K filings.
5.90 in FY2024 with a 5-year CAGR of -21.2%.
Declined from $8.18 to $5.90 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -6.7%
- 5-Year CAGR
- -21.2%
- 10-Year CAGR
- -
Sector benchmark
#137 of 208 in Health CareTop 66% of 208This company $5.90 Sector average $377.57
▼
-98.4% below sector average
Key checks
Key Insights
- In FY2024, assets per share increased 30.4% year-over-year.
- Ranks #137 out of 208 companies in the Health Care sector.
- Peak assets per share was recorded in FY2018.
- Lowest assets per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.38 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $5.90 | +30.4% |
| FY2023 | $4.52 | -44.7% |
| FY2022 | $8.18 | +12.8% |
| FY2021 | $7.25 | +47.1% |
| FY2020 | $4.93 | -74.7% |
| FY2019 | $19.46 | -82.6% |
| FY2018 | $111.86 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026